Bicavitary eosinophilic effusion in a dog with coccidioidomycosis

J Vet Intern Med. 2020 Jul;34(4):1582-1586. doi: 10.1111/jvim.15810. Epub 2020 May 24.

Abstract

This is a case of coccidioidomycosis in a dog, examined for vomiting and labored breathing. Physical examination and thoracic and abdominal imaging revealed pleural and peritoneal effusions, both of which exhibited neutrophilic inflammation with a substantial eosinophilic component. The dog had positive IgM and IgG coccidioidomycosis titers at initial evaluation. The eosinophilic component of the inflammation was attributed to coccidioidomycosis. The dog underwent approximately 6 months of fluconazole treatment, with both effusions and clinical signs improving after 6 weeks. Three months after cessation of antifungal treatment, the dog developed a mid-diaphyseal lytic and proliferative lesion in the left radius caused by Coccidioides spp. This case illustrates the importance of consideration of coccidioidomycosis when an eosinophilic cavitary effusion is present in dogs that live in or have traveled to endemic regions.

Keywords: Valley Fever; coccidioides; cytology; fungal disease; infectious disease.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Antifungal Agents / therapeutic use
  • Ascitic Fluid*
  • Bone Diseases / microbiology
  • Bone Diseases / veterinary
  • Coccidioides / isolation & purification
  • Coccidioidomycosis / diagnosis
  • Coccidioidomycosis / drug therapy
  • Coccidioidomycosis / veterinary*
  • Dog Diseases / diagnosis*
  • Dog Diseases / drug therapy
  • Dogs
  • Exudates and Transudates / chemistry
  • Exudates and Transudates / cytology
  • Fluconazole / therapeutic use
  • Male
  • Pleural Effusion / veterinary*
  • Recurrence

Substances

  • Antifungal Agents
  • Fluconazole